The Sick Times
  • Sections
    • Arts & Culture
    • Commentary
    • COVID-19
    • Health
    • International
    • Podcast
    • Policy & Advocacy
    • Science
  • About
    • Our team
    • Write for us
    • Transparency & policies
  • Resources
Newsletter
Donate
  • Department of Defense funds $8 million grant for Long COVID trials

    Department of Defense funds $8 million grant for Long COVID trials

    Betsy Ladyzhets

    A new U.S. clinical trials program called PROBE-PASC was announced on Friday at a Long COVID conference in Amsterdam. The program received initial funding of $8 million from a Department of Defense (DOD) grant. Read more…

Recent articles

  • National COVID-19 trends, September 1
    COVID-19
    Betsy Ladyzhets

    National COVID-19 trends, September 1

  • Research updates, September 1
    Science
    Miles W. Griffis

    Research updates, September 1

  • “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID
    Commentary
    Kelly Sealey

    “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID

Get the latest Long COVID news and commentary

Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

Check out our weekly podcast, Still Here

SpotifySpotifyApple PodcastsApple PodcastsPocketCastsPocketCastsiHeartRadioiHeartRadioRSSRSS

Trending

Department of Defense funds $8 million grant for Long COVID trialsDepartment of Defense funds $8 million grant for Long COVID trialsBetsy Ladyzhets
“We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID“We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVIDKelly Sealey
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?Miles W. Griffis
National COVID-19 trends, September 1National COVID-19 trends, September 1Betsy Ladyzhets
Research updates, September 1Research updates, September 1Miles W. Griffis

Policy & Advocacy

  • November 21, 2023

    The HHS invites nominees for a new committee on Long Covid, but will it listen to them?

Previous Page
1 … 16 17 18

Science

  • man industry technology white
    May 27, 2025

    Research updates, May 27

  • Diagram showing how SARS-CoV-2 infection can lead to damaged mitochondria and damaged myofibrillar (or muscle protein) bundles, contributing to Long COVID cardiovascular outcomes
    May 20, 2025

    Research updates, May 20

  • Electron micrograh image of a cell infected with SARS-CoV-2. the cell appears as a large, teal blog, with viral particles in purple invading across its surface
    May 16, 2025

    Live blog: Following the Spring 2025 PolyBio Symposium on Long COVID and related diseases

  • a woman in purple scrub suit wearing blue mask
    May 13, 2025

    Research updates, May 13

  • Collage graphic with a background showing Santa Fe, New Mexico, a portrait of Hannah Davis with a red background, and a text box with the Keystone Symposia logo and the text: "Long COVID and Other Post-Acute Infection Syndromes, August 10-13, 2025, Eldorado Hotel & Spa, Santa Fe, NM, US"
    May 9, 2025

    “A morale boost”: Looking ahead to the 2025 Keystone Symposia Long COVID conference with Hannah Davis

  • people walking at the hallway while carrying medical supplies
    May 6, 2025

    Research updates, May 6

Previous Page
1 … 16 17 18 19 20 … 38
Next Page

Covid-19

  • A DIY air filter, made with 18 fans facing out in different directions, is attached to a ceiling light fixture so that it hangs in the air above a dining table.
    December 24, 2024

    Invisible defenses: A guide for cleaner indoor air

  • Two state-by-state maps of the U.S., color-coded according to infectious disease trends. Dark purple represents infections are growing, light purple is likely growing, gray is not changing, light green is likely declining, dark green is declining, white is not estimated. The map on the left, showing COVID-19 trends, is a mix of light and dark purple with some gray. Text at the top reads: "As of December 17, 2024, we estimate that COVID-19 infections are growing or likely growing in 36 states, declining or likely declining in 0 states, and not changing in 11 states." The map on the right, showing flu trends, is almost entirely dark purple. Text at the top reads: "As of December 17, 2024, we estimate that influenza infections are growing or likely growing in 46 states, declining or likely declining in 0 states, and not changing in 1 state."
    December 24, 2024

    National COVID-19 trends, December 24

  • Title: "This chart shows national and regional trends of wastewater viral activity levels of SARS-COV-2 (the virus that causes COVID-19)." The chart is set to show data from the last six months, or June to early December 2024. It shows a major surge across regions (highest in the West coast) over the summer, followed by a plateau over October and November, and recently a new, stark uptick in disease levels. The Midwest has the highest levels and most prominent increase compared to other regions.
    December 17, 2024

    National COVID-19 trends, December 17

  • Line chart showing national average SARS-CoV-2 levels in U.S. wastewater over time, October 2023 through December 2024. The title reads, "SARS–CoV–2, All Wastewater Sites." The Y axis shows quantity of nucleic acids, PMMoV Normalized x 1 million, and the X axis shows sample collection date. The chart shows a major wave in fall 2023-early 2024 and a second one in summer 2024, followed by a moderate plateau over October and November. Disease levels started going up again at the end of November.
    December 10, 2024

    National COVID-19 trends, December 10

  • Two state-by-state maps are presented side by side. In both, states are colored according to epidemic trends: growing and likely growing in dark and light purple, declining and likely declining in dark and light green, not changing in gray, not estimated in white. The map on the left, representing COVID-19, has a mix of green and purple. Text above it reads: "As of November 26, 2024, we estimate that COVID-19 infections are growing or likely growing in 10 states, declining or likely declining in 15 states, and not changing in 22 states." The map on the right, representing influenza, has more purple and only one state in green. Text above it reads: "As of November 26, 2024, we estimate that influenza infections are growing or likely growing in 33 states, declining or likely declining in 1 state, and not changing in 8 states."
    December 3, 2024

    National COVID-19 trends, December 3

  • Line chart titled, "Percentage of Outpatient Visits for Respiratory Illness Reported by the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet), Weekly National Summary, 2024-25 Season and Selected Previous Seasons." The Y axis shows % of visits for influenza-like illness (ILI) while the X axis shows time in the flu season. ILI visits have been increasing over the last few weeks, as shown with a red line on the chart (2024-25 season), and are progressing similarly to the 2019-20 season (light blue line). The most recent data point, about 2.7%, is close to the threshold for flu season at 3%.
    November 26, 2024

    National COVID-19 trends, November 26

Previous Page
1 … 16 17 18 19 20 … 31
Next Page

Health

  • June 21, 2024

    The short reach of Long Covid care

  • June 11, 2024

    New Long Covid and ME apps aim to share information, build community

  • May 14, 2024

    #MEAction launches campaign to educate healthcare providers about Myalgic Encephalomyelitis

  • April 30, 2024

    Bird flu is spreading through U.S. farms. What are the risks to people?

  • April 18, 2024

    ‘People need help now’—Why NYC’s unique Long Covid programs aren’t enough

  • April 9, 2024

    Hidden disability: The quiet struggle with Long Covid in Kenya

Previous Page
1 … 16 17 18 19 20
Next Page

Commentary

  • November 14, 2023

    Welcome to The Sick Times, a letter from our co-founder, Betsy Ladyzhets

  • woman in beige coat standing near white wooden book shelf
    November 14, 2023

    We want to hear from you! Take our reader survey

Previous Page
1 … 25 26 27

The Sick Times is an independent news site founded by journalists Betsy Ladyzhets and Miles Griffis. We report on the Long COVID crisis, COVID-19, and infection-associated illnesses.

Contact:
editors@thesicktimes.org

PO Box 331009
Brooklyn, NY 11233

  1. Home
  2. About
  3. Newsletter
  4. Podcast
  5. Transparency & policies
  6. Write for us
  7. Resources
  8. Donate
  • Twitter
  • Instagram
  • YouTube
  • Facebook
  • Bluesky

Sign up for our free newsletter, delivered every Tuesday. Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list 🙂
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

© 2026 The Sick Times

Loading Comments...